Literature DB >> 10937844

Role of endothelium and vasoconstrictor prostanoids in norepinephrine-induced vasoconstriction in isolated rat common carotid arteries.

N Furuhashi1, S Miyazaki, M Kamura, S Emura, K Yasuda.   

Abstract

We investigated the role of endothelium and vasoconstrictor prostanoids in the norepinephrine (NE)-induced vasoconstriction of isolated rat common carotid arteries (CCAs). Isolated CCAs were cannulated with stainless steel cannulae by the cannula inserting method. NE was administered intra- or extraluminally by a single microinjection. For denudation of endothelium, the intimal surface was gently rubbed with a cotton pellet. NE produced dose-related vasoconstricting responses in isolated arteries with intact endothelium. These responses were attenuated by pretreatment with denudation, OKY046, a thromboxane A2 synthesis inhibitor or indomethacin. The residual responses after denudation were further blocked by OKY046 or indomethacin. All NE-induced responses were blocked by a single injection of prazosin. There were no significant differences in responses between intra- and extraluminal administration of NE. These results show that most vasoconstriction induced by NE via alpha1-adrenoceptors in CCAs is dependent on vasoconstrictor prostanoids distributed both in endothelium and vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937844     DOI: 10.1081/ceh-100100090

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

Review 1.  Vascular hyper-reactivity following arterial balloon injury: distant and delayed effects.

Authors:  Andrew J Wilson
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

2.  The balloon catheter induces an increase in contralateral carotid artery reactivity to angiotensin II and phenylephrine.

Authors:  D Accorsi-Mendonça; F M A Corrêa; T B Paiva; H P de Souza; F R M Laurindo; A M de Oliveira
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.